FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuits News and commentary from the endocrinology world Sep 26, 2023
The GLP-1 Agonist Plateau No One's Talking About Weight stabilization is no surprise to specialists, but for patients it's more complicated Sep 22, 2023
Over One-Third of Adults in 22 States Have Obesity, CDC Says No states hit this threshold a decade ago Sep 22, 2023
Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical? News and commentary from the endocrinology world Sep 19, 2023
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
Weight-Loss Surgery Tied to Lower Blood Cancer Risk in Women Consider surgery for primary prevention in people with obesity, researchers suggest Sep 15, 2023
New Weight-Loss Drugs Spark Debate About Safety During Surgery Some anesthesiologists think current guidelines don't go far enough Sep 08, 2023
Endocrine Disruptors in Paper Straws; Wegovy's CV Benefit; Stroke and Infertility Tx News and commentary from the endocrinology world Sep 05, 2023
Real-World Data Back ECMO Use in Critically Ill Patients With Obesity Obesity should not be considered a contraindication for use, say researchers Aug 30, 2023
Insulin Calculator Cleared; Twice-Rejected Diabetes Drug; Ozempic for Alcohol Use? News and commentary from the endocrinology world Aug 29, 2023
'Big Win' for Anti-Obesity Medication in Heart Failure Semaglutide led to meaningful reductions in symptoms, weight in patients with obesity and HFpEF Aug 29, 2023 video
Wegovy Reduces Heavy Symptom Burden of Obesity-Related Heart Failure Heart failure with preserved ejection fraction and obesity becoming more common Aug 25, 2023
Liver Concerns Foil GLP-1 Drug; Not Enough Menopause Training; Wegovy Supply Limits News and commentary from the endocrinology world Aug 15, 2023
Clinically Significant Weight Loss Uncommon for Most Overweight Adults Only one in 10 with overweight or obesity achieve 5% or greater weight loss each year Aug 07, 2023
Unexplained Heart Enlargement May Be Causing Sudden Deaths in Obesity Increased ventricular mass without the usual etiologies of heart disease was noted Jul 28, 2023
Trial Supports GLP-1 After Underwhelming Metabolic Surgery Helped more patients achieve clinically significant weight loss Jul 27, 2023
Gastric Bypass Surgery Tied to Higher Risk of Substance Use Disorder Prior findings from same cohort showed link between alcohol use disorder and bariatric surgery Jul 21, 2023
Aspartame Is a 'Possible' Carcinogen, WHO Declares But the organization's recommended limits on aspartame consumption remain unchanged Jul 13, 2023
'Overweight' BMI Not Tied to Higher Risk of Death, U.S. Data Suggest Though clear link seen for BMIs of 30 and above Jul 07, 2023
Medical Spending Higher for Kids Outside Healthy Weight Limits Expenditures tied to underweight and obesity totaled $1 billion and $2.4 billion in 2018 Jul 03, 2023
ASA: Hold GLP-1 Agonists Before Elective Surgery Or else run the risk of aspirating under anesthesia due to delayed gastric emptying Jun 30, 2023
Yet Another Injectable Combo Achieves Near 15% Weight Loss in Trial But GI side effects higher than other comparable anti-obesity agents Jun 27, 2023
BMI Alone Falling Out of Favor as a Way to Assess Healthy Weight Tool is still useful, but should be used in concert with other measures, experts suggest Jun 27, 2023
When Wegovy Doesn't Work for Weight Loss Some people just don't respond; others have such severe side effects they need to stop Jun 27, 2023
Semaglutide Plus Cagrilintide Reduced Blood Sugar, Weight in T2D Once-weekly CagriSema reduced body weight more than either agent alone Jun 27, 2023
High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Loss Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023
Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease Jun 26, 2023
Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trial Daily orforglipron also lowered HbA1c in type 2 diabetes Jun 24, 2023
Expunge Nazi-Era Medical Terms? Off-Brand Wegovy Clinics Sued; Copy and Paste Bloat Health news and commentary from around the Web gathered by ·¬ΗΡΙηΗψ staff Jun 21, 2023
ENDO 2023 Roundup: More Imcivree Data; Statement on Aging; Novel Hypoparathyroid Tx Some more highlights from the Endocrine Society's annual meeting Jun 20, 2023
Type 2 Diabetes Cases in Kids Still Rising After 'Return to Normal' Once they returned to school, we thought things would normalize, researcher says Jun 20, 2023
Early Time-Restricted Eating Cut Blood Sugar Fluctuations in Prediabetes Effects in small study seen independent of weight loss Jun 18, 2023
Breast Cancer Drugs May Weaken Effects of Weight-Loss Drugs Survivors on aromatase inhibitors lost significantly less weight Jun 18, 2023
Clinicians: Pay Attention to Body Image Concerns in Patients With PCOS The first step is "acknowledging it, supporting, and listening," researcher says Jun 18, 2023
BMI vs Body Fat Percentage: Measures Conflict When Classifying Obesity Clinicians should not rely solely on BMI for measuring obesity, researcher says Jun 16, 2023
High-Dose Leptin Reversed Severe Genetic Obesity in Two Patients Metreleptin doses several times higher than recommended brought weight down to near normal Jun 14, 2023
Better Weight Outcomes for Kids With Family-Based Approach in Primary Care Program worked better than usual care, but was less effective than expected Jun 13, 2023
Could Semaglutide Help Curb Addictive Behaviors? Many unanswered questions should elicit attention and caution, experts say Jun 02, 2023
Is Berberine Really 'Nature's Ozempic'? An obesity medicine specialist shares his insights on the new social media craze Jun 02, 2023
